Literature DB >> 34406907

Pretransplant Antifibrotic Therapy Is Associated with Resolution of Primary Graft Dysfunction.

Michael P Combs1, Linda J Fitzgerald1, Elliot Wakeam1, Dennis M Lyu1, David N O'Dwyer1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34406907      PMCID： PMC8867361          DOI： 10.1513/AnnalsATS.202106-736RL

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN： 2325-6621


× No keyword cloud information.
  10 in total

1.  Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1.

Authors:  Christopher M Burton; Martin Iversen; Jørn Carlsen; Jann Mortensen; Claus B Andersen; Daniel Steinbrüchel; Thomas Scheike
Journal:  J Heart Lung Transplant       Date:  2009-09       Impact factor: 10.247

2.  Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy.

Authors:  Gabriela Leuschner; Florian Stocker; Tobias Veit; Nikolaus Kneidinger; Hauke Winter; René Schramm; Thomas Weig; Sandhya Matthes; Felix Ceelen; Paola Arnold; Dieter Munker; Friederike Klenner; Rudolf Hatz; Marion Frankenberger; Jürgen Behr; Claus Neurohr
Journal:  J Heart Lung Transplant       Date:  2017-07-05       Impact factor: 10.247

3.  Risk of anastomotic dehiscence in patients with pulmonary fibrosis transplanted while receiving anti-fibrotics: Experience of the Australian Lung Transplant Collaborative.

Authors:  John A Mackintosh; Maitri Munsif; Lucy Ranzenbacher; Claire Thomson; Michael Musk; Gregory Snell; Allan Glanville; Daniel C Chambers; Peter Hopkins
Journal:  J Heart Lung Transplant       Date:  2019-02-12       Impact factor: 10.247

4.  Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT.

Authors:  Geert M Verleden; Allan R Glanville; Erika D Lease; Andrew J Fisher; Fiorella Calabrese; Paul A Corris; Christopher R Ensor; Jens Gottlieb; Ramsey R Hachem; Vibha Lama; Tereza Martinu; Desley A H Neil; Lianne G Singer; Greg Snell; Robin Vos
Journal:  J Heart Lung Transplant       Date:  2019-04-03       Impact factor: 10.247

5.  Pirfenidone exerts beneficial effects in patients with IPF undergoing single lung transplantation.

Authors:  Tobias Veit; Gabriela Leuschner; Alma Sisic; Felix Ceelen; Dieter Munker; Magdalena Schmitzer; Thomas Weig; Sebastian Michel; Christian Schneider; Bruno Meiser; Alexander Crispin; Claus Neurohr; Jürgen Behr; Katrin Milger; Nikolaus Kneidinger
Journal:  Am J Transplant       Date:  2019-04-29       Impact factor: 8.086

Review 6.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: Definition and grading-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation.

Authors:  Gregory I Snell; Roger D Yusen; David Weill; Martin Strueber; Edward Garrity; Anna Reed; Andres Pelaez; Timothy P Whelan; Michael Perch; Remzi Bag; Marie Budev; Paul A Corris; Maria M Crespo; Chad Witt; Edward Cantu; Jason D Christie
Journal:  J Heart Lung Transplant       Date:  2017-07-26       Impact factor: 10.247

7.  Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation.

Authors:  Rupal J Shah; Joshua M Diamond; Edward Cantu; James C Lee; David J Lederer; Vibha N Lama; Jonathan Orens; Ann Weinacker; David S Wilkes; Sangeeta Bhorade; Keith M Wille; Lorraine B Ware; Scott M Palmer; Maria Crespo; A Russell Localio; Ejigayehu Demissie; Steven M Kawut; Scarlett L Bellamy; Jason D Christie
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

8.  Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.

Authors:  Susan Stewart; Michael C Fishbein; Gregory I Snell; Gerald J Berry; Annette Boehler; Margaret M Burke; Alan Glanville; F Kate Gould; Cynthia Magro; Charles C Marboe; Keith D McNeil; Elaine F Reed; Nancy L Reinsmoen; John P Scott; Sean M Studer; Henry D Tazelaar; John L Wallwork; Glen Westall; Martin R Zamora; Adriana Zeevi; Samuel A Yousem
Journal:  J Heart Lung Transplant       Date:  2007-12       Impact factor: 10.247

9.  Pirfenidone alleviates lung ischemia-reperfusion injury in a rat model.

Authors:  Masao Saito; Toyofumi F Chen-Yoshikawa; Kimitaka Suetsugu; Ryo Okabe; Akihiro Takahagi; Satohiro Masuda; Hiroshi Date
Journal:  J Thorac Cardiovasc Surg       Date:  2018-09-28       Impact factor: 5.209

10.  Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series.

Authors:  Isabelle Delanote; Wim A Wuyts; Jonas Yserbyt; Eric K Verbeken; Geert M Verleden; Robin Vos
Journal:  BMC Pulm Med       Date:  2016-11-18       Impact factor: 3.317
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.